🇺🇸 FDA
Pipeline program

Ramelteon

2007P-001929

Approved small_molecule completed

Quick answer

Ramelteon for Schizophrenia is a Approved program (small_molecule) at TAKEDA PHARMACEUTICAL CO LTD with 1 ClinicalTrials.gov record(s).

Program details

Company
TAKEDA PHARMACEUTICAL CO LTD
Indication
Schizophrenia
Phase
Approved
Modality
small_molecule
Status
completed

Clinical trials